Shenlian Bio completes share repurchase program

Shanghai Shenlian Biomedical Corporation (SSE:688098) announced the completion of its share repurchase program, initiated on November 26, 2024. The company repurchased 3,417,373 shares, representing 0.8322% of the total share capital. The repurchases were conducted through centralized bidding, with prices ranging from CNY 5.47 to CNY 6.29 per share, resulting in a total expenditure of CNY 20,000,452.13. The repurchased shares are intended for future employee stock ownership plans, equity incentives, or conversion into company bonds. Any shares not used within three years will be cancelled.